RecruitingNCT06931457

Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet Rich Plasma to Treat Idiopathic Glossopharyngeal Neuralgia (GPN)

Efficacy and Safety of the Application of Pulsed Radiofrequency, Combined With Platelet Rich Plasma, to the Treatment of Idiopathic Glossopharyngeal Neuralgia (GPN): A Study Protocol for a Multi-Center, Prospective, Open-Label, Propensity Score Match Cohort Study

Sponsor

Beijing Tiantan Hospital

Enrollment

121 participants

Start Date

May 1, 2025

Study Type

OBSERVATIONAL

Conditions

Pulsed Radiofrequency Glossopharyngeal Neuralgia

Summary

To investigate the efficacy and safety of the application of PRF combined PRP to the for the treatment of GPN.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

age \>18 years;
diagnosed with idiopathic GPN according to the third International Classification of Headache Disorders (ICHD) classification;
patients who failed pharmacotherapy or intolerable side effects of medication;
undergoing PRF for GPN;
at least 1 month of follow-up recordings.

Exclusion Criteria9

Patients with bilateral GPN;
Abnormalities in blood measurements, liver and kidney function, blood glucose, coagulation, electrocardiography or chest radiography;
Infection at the puncture site;
Previous mental illness;
Previous history of narcotic drug abuse;
Prior anticoagulant or antiplatelet therapy;
An implantable pulse generator;
Current pregnancy or breast feeding.
Patients with incomplete medical records (lack of baseline data or postoperative follow-up data).

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.